AeroLeads people directory · profile

Brian Meehan Email & Phone Number

Microbiologist, Drug Hunter, Team Leader at ClostraBio, Inc
Location: Boston, Massachusetts, United States 10 work roles 3 schools
1 work email found @harvard.edu LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email b****@harvard.edu
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Microbiologist, Drug Hunter, Team Leader
Location
Boston, Massachusetts, United States

Who is Brian Meehan? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Brian Meehan is listed as Microbiologist, Drug Hunter, Team Leader at ClostraBio, Inc, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at harvard.edu and a matched LinkedIn profile for Brian Meehan.

Brian Meehan previously worked as Chief Science Officer at Clostrabio, Inc and Microbiome Consultant at Self-Employed. Brian Meehan holds Doctor Of Philosophy (Ph.D.), Microbiology And Molecular Biology from Tufts University.

Company email context

Email format at ClostraBio, Inc

This section adds company-level context without repeating Brian Meehan's masked contact details.

{first}_{last}@harvard.edu
86% confidence

AeroLeads found 1 current-domain work email signal for Brian Meehan. Compare company email patterns before reaching out.

Profile bio

About Brian Meehan

I am an experienced microbiologist and molecular biologist with a strong interest in developing novel therapeutics surrounding the human microbiome.

Listed skills include Research, Molecular Biology, Science, Teaching, and 13 others.

Current workplace

Brian Meehan's current company

Company context helps verify the profile and gives searchers a useful next step.

ClostraBio, Inc
Clostrabio, Inc
Microbiologist, Drug Hunter, Team Leader
AeroLeads page
10 roles

Brian Meehan work experience

A career timeline built from the work history available for this profile.

Chief Science Officer

Current

Chicago, Il, Us

Oct 2024 - Present

Microbiome Consultant

Current
Self-Employed

Specializing in helping early-stage biotechs identify and develop microbiome-directed therapeutics with experience in :-Early stage discovery-Live microbe manufacturing-Regulatory strategy (IND vs. GRAS)-Biomarker identification-Clinical design

Apr 2023 - Present

Head Of Microbiology

Pareto Bio, Inc.

As Pareto's first employee, I have made major contributions to every facet of company development, consistently producing results ahead of schedule and under budget in a quest to treat food allergies in children.After establishing and outfitting our research laboratory, I developed and implemented a vision for our scientific platform. To realize this vision, I defined and implemented protocols for all microbiology and molecular biology activities and hired, trained, and supervised research associates who executed large-scale screenings of bacterial isolates for safety and multi-dimensional functional outputs. Ultimately, I oversaw the selection of Pareto's first candidate product, a bacterial consortium designed to promote immune tolerance. The therapeutic potential of this consortium was supported by work from our lab (with the help of a CRO) demonstrating efficacy in the gold-standard animal model of disease. With the efficacy of our lead product confirmed, I led efforts to manufacture and formulate it for maximum potency alongside our CDMO partner. This has so far resulted in the successful production of drug substance for all of our (strictly anaerobic) strains. Along the way I developed novel manufacturing protocols that have led to IP filings.While driving development of our product candidate, I have authored critical sections of FDA filings and contributed to the design of our first in human clinical trials, in part by identifying appropriate biomarkers.

Oct 2020 - Jan 2023

Associate Director, Biology

Lexington, Massachusetts, Us

Led research team that identified KB195, our lead compound for treating hyperammonemia associated with urea cycle disorders via the gut microbiome• Coordinated and executed early-stage discovery efforts• Contributed to writing of regulatory filings with the FDA and met face-to-face with regulators to discuss developmental path for KB195 Resulted in Kaleido’s first successful IND.

Jan 2019 - Oct 2020

Senior Scientist

Lexington, Massachusetts, Us

• Met with known opinion leaders (KOLs) as part of advisory boards in the U.S. and Europe• Contributed to IP filings• Initiated and managed relationships with contract research organizations (CROs)• Managed Masters-level scientist and mentored several others• Actively contributed to company culture by organizing scientific talks for non-scientists, mentoring young scientists in critical skills, creating KaleidOlympics, organizing coat drive, etc.

Jan 2018 - Jan 2019

Postdoctoral Fellow

Boston, Ma, Us

My work in the Beckwith lab focused on understanding how the periplasmic disulfide bond (DSB) formation pathway in E. coli contributes to the growth and virulence of this organism under low oxygen conditions. We employed a high-throughput approach to identify small molecule inhibitors of this DSB system, and I characterized several of these small molecules to elucidate their mechanism of action and to identify mutations that render E. coli (and other Gram-negatives) resistant to such compounds.

Sep 2011 - Oct 2016

Graduate Student/Postdoctoral Fellow

Medford, Massachusetts, Us

As a graduate student my work focused on the molecular mechanisms underlying strict anaerobiosis in bacteria. Specifically, I sought to answer the question, "What makes an anaerobe an anaerobe?"I worked extensively with bacteria associated with the human gut microbiome (like Bacteroides and Clostridia) to understand how the metabolic networks of these strict anaerobes responded to oxygen. I identified and characterized mutations that allowed these organisms to grow in 40-times more oxygen than they were normally capable of tolerating, and investigated numerous metabolic pathways to determine the extent of oxidative damage. Much of my work focused on amino sugar utilization by Bacteroides fragilis, as this pathway appeared to be a critical interface between oxygen tolerance and growth in the gut.

Aug 2003 - Sep 2011

Agroforestry Extensionist

Washington, District Of Columbia, Us

Jun 1998 - Aug 2000
3 education records

Brian Meehan education

Doctor Of Philosophy (Ph.D.), Microbiology And Molecular Biology

Tufts University

Bachelor Of Science (B.S.), Biology

University Of Notre Dame

Education record

Marist High School
FAQ

Frequently asked questions about Brian Meehan

Quick answers generated from the profile data available on this page.

What company does Brian Meehan work for?

Brian Meehan works for ClostraBio, Inc.

What is Brian Meehan's role at ClostraBio, Inc?

Brian Meehan is listed as Microbiologist, Drug Hunter, Team Leader at ClostraBio, Inc.

What is Brian Meehan's email address?

AeroLeads has found 1 work email signal at @harvard.edu for Brian Meehan at ClostraBio, Inc.

Where is Brian Meehan based?

Brian Meehan is based in Boston, Massachusetts, United States while working with ClostraBio, Inc.

What companies has Brian Meehan worked for?

Brian Meehan has worked for Clostrabio, Inc, Self-Employed, Pareto Bio, Inc., Kaleido Biosciences, and Harvard Medical School.

How can I contact Brian Meehan?

You can use AeroLeads to view verified contact signals for Brian Meehan at ClostraBio, Inc, including work email, phone, and LinkedIn data when available.

What schools did Brian Meehan attend?

Brian Meehan holds Doctor Of Philosophy (Ph.D.), Microbiology And Molecular Biology from Tufts University.

What skills is Brian Meehan known for?

Brian Meehan is listed with skills including Research, Molecular Biology, Science, Teaching, Data Analysis, Cell Culture, Biochemistry, and Genetics.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.